SWOT Analysis for Krystal Biotech Inc - Threats

Add SWOT widget to your site/app

Stocks in Buy Zone with High Momentum Score Last Month

Consistent Highest Return Stocks over Five Years - Nifty500

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over the Quarter (3 Months)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Month

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Increasing profits every quarter for the past 3 quarters

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding

Companies with growing costs YoY for long term projects

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

High PE (PE > 40)

Oversold by Money Flow Index (MFI)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining Net Cash Flow : Companies not able to generate net cash

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts

Institutions increasing their shareholding

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Expensive Performers (DVM)